279 related articles for article (PubMed ID: 35711429)
1. IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2.
Olguín-Martínez E; Muñoz-Paleta O; Ruiz-Medina BE; Ramos-Balderas JL; Licona-Limón I; Licona-Limón P
Front Immunol; 2022; 13():787713. PubMed ID: 35711429
[TBL] [Abstract][Full Text] [Related]
2. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
3. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
5. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.
Sunaga S; Tsunoda J; Teratani T; Mikami Y; Kanai T
Front Immunol; 2022; 13():867351. PubMed ID: 35707544
[TBL] [Abstract][Full Text] [Related]
7. Cutting Edge: CCR8 Signaling Regulates IL-25- and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function.
Sun Z; Sen H; Zhu X; Islam SA
J Immunol; 2023 Dec; 211(12):1751-1755. PubMed ID: 37921466
[TBL] [Abstract][Full Text] [Related]
8. Identification of two migratory colon ILC2 populations differentially expressing IL-17A and IL-5/IL-13.
Liu H; Li L; Hao Y; Li J; Liu Z; Qi J; Zhang J; Wu N; Wu D; Gao C; Chen L; Shen L; Cheng J; Su B
Sci China Life Sci; 2023 Jan; 66(1):67-80. PubMed ID: 35881219
[TBL] [Abstract][Full Text] [Related]
9. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
10. The ST2
Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
[TBL] [Abstract][Full Text] [Related]
11. An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis.
Zhao Y; De Los Santos FG; Wu Z; Liu T; Phan SH
J Pathol; 2018 Aug; 245(4):399-409. PubMed ID: 29722022
[TBL] [Abstract][Full Text] [Related]
12. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between ILC2s and Th2 cells varies among mouse models.
Gurram RK; Wei D; Yu Q; Butcher MJ; Chen X; Cui K; Hu G; Zheng M; Zhu X; Oh J; Sun B; Urban JF; Zhao K; Leonard WJ; Zhu J
Cell Rep; 2023 Feb; 42(2):112073. PubMed ID: 36735533
[TBL] [Abstract][Full Text] [Related]
14. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis.
Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q
Front Immunol; 2021; 12():670676. PubMed ID: 33995408
[TBL] [Abstract][Full Text] [Related]
15. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
16. Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung.
Bando JK; Nussbaum JC; Liang HE; Locksley RM
J Leukoc Biol; 2013 Nov; 94(5):877-84. PubMed ID: 23924659
[TBL] [Abstract][Full Text] [Related]
17. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
18. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
19. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
[TBL] [Abstract][Full Text] [Related]
20. HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.
Wang Z; Yan C; Du Q; Huang Y; Li X; Zeng D; Mao R; Gurram RK; Cheng S; Gu W; Zhu L; Fan W; Ma L; Ling Z; Qiu J; Li D; Liu E; Zhang Y; Fang Y; Zhu J; Sun B
Cell Mol Immunol; 2023 Apr; 20(4):404-418. PubMed ID: 36823235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
